Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

Share Price is delayed by 15 minutes
Get Live Data
5.75    -0.10 (-1.71%)
Bid:
5.70
Ask:
5.80
Spread: 0.10 (1.754%)
Market Cap: £61.50m
STX Live PriceLast checked at - London Stock Exchange

Intraday Shield Thera Share Chart

Shield Thera News

LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels
26 Feb 2021

LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels

LONDON TRADING UPDATES: Castings Hails Return To Pre-Covid Levels

AIM WINNERS & LOSERS: K3 Business Rises On Starcom Technologies Sale
26 Feb 2021

AIM WINNERS & LOSERS: K3 Business Rises On Starcom Technologies Sale

AIM WINNERS & LOSERS: K3 Business Rises On Starcom Technologies Sale

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash
29 Jan 2021

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

TRADING UPDATES: Character Extends Peppa Pig Deal; Dekel Raises Cash

DIRECTOR DEALINGS SUMMARY: New U&I Group CEO Upton Buys Shares
21 Jan 2021

DIRECTOR DEALINGS SUMMARY: New U&I Group CEO Upton Buys Shares

DIRECTOR DEALINGS SUMMARY: New U&I Group CEO Upton Buys Shares

DIRECTOR DEALINGS: Shield Therapeutics CEO Buys 100,000 Shares
19 Jan 2021

DIRECTOR DEALINGS: Shield Therapeutics CEO Buys 100,000 Shares

DIRECTOR DEALINGS: Shield Therapeutics CEO Buys 100,000 Shares

IN BRIEF: Shield Therapeutics Expects Increase In Annual Revenue
15 Jan 2021

IN BRIEF: Shield Therapeutics Expects Increase In Annual Revenue

IN BRIEF: Shield Therapeutics Expects Increase In Annual Revenue

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares
14 Dec 2020

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

IN BRIEF: Shield Therapeutics Shares Drop As Eyes US Push On Its Own
11 Dec 2020

IN BRIEF: Shield Therapeutics Shares Drop As Eyes US Push On Its Own

IN BRIEF: Shield Therapeutics Shares Drop As Eyes US Push On Its Own